# US 2008/0076164 A1 · Method for Increasing the Content of Polyunsaturated Long-Chained Fatty Acids in Transgenic Organisms

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0076164 A1
- Document ID: US20080076164A1
- Status: Published application
- Kind: A1
- Application number: 11/632,555
- Filed: 2005-07-15
- Published: 2008-03-27
- Earliest claimed: 2004-07-16
- Assignees: BASF Plant Science GmbH
- Inventors: Petra Cirpus; Jorg Bauer; Xiao Qiu; Patricia Vrinten
- Web page: https://patentgrep.com/patent/US20080076164A1

## CPC

- C12N 9/0006: {acting on CH-OH groups as donors (1.1)}
- C12N 9/20: Triglyceride splitting, e.g. by means of lipase
- C12N 9/88: Lyases (4.)
- C12N 15/8247: {involving modified lipid metabolism, e.g. seed oil composition}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention relates to a method for increasing the content of polyunsaturated long-chain fatty acids in an organism by introducing into said organism nucleic acids coding for polypeptides or proteins exhibiting a phospholipase, ketoacyl-CoA reductase and/or dehydratase activity. Advantageously, said enzymes originate from Ostreococcus or Thraustochytrium. The present invention further relates to the nucleic acid sequences, nucleic acid constructs, vectors and organisms containing the nucleic acid sequences according to the present invention, vectors containing the nucleic acid sequences and/or the nucleic acid constructs as well as to transgenic organisms containing the above mentioned nucleic acid sequences, nucleic acid constructs and/or vectors. Advantageously, said previously mentioned nucleic acid sequences, nucleic acid constructs, vectors can optionally be expressed in the organism together with further nucleic acid sequences coding for polypeptides or proteins of the biosynthesis of the fatty acid or lipid metabolism. Particularly advantageous herein are those nucleic acid sequences of the fatty acid or lipid metabolism that code for a Δ-9 elongase, Δ-8 desaturase, Δ-6 desaturase, a Δ-5 desaturase, Δ-4 desaturase, Δ-12 desaturase, Δ-5 elongase and/or Δ-6 elongase activity. Advantageously, said desaturases and elongases originate from organisms like Thalassiosira, Euglena, Isochrysis, Physcomitrella, Thraustochytrium, Borago, Phytophthora, Crypthecodinium, Oncorhynchus, Primula, Xenopus, Ciona, Arabidopsis, Mortierella, Caenorhabditis, Phaeodactylum, Ceratodon or Ostreococcus. A further part of the present invention relates to oils, lipids and/or fatty acids produced according to the method of the present invention and the use thereof. Furthermore, the present invention relates to unsaturated fatty acids and triglycerides having an increased content of unsaturated fatty acids and the use thereof.

## Claims

### Claim at position 1

1-26. (canceled)

### Claim 27

A method for producing oils and/or lipids having a high content of polyunsaturated fatty acids containing at least two double bonds in a transgenic organism comprising:
a) introducing at least one nucleic acid sequence coding for a phospholipase A2 activity into the organism, or
b) introducing at least one nucleic acid sequence coding for a ketoacyl-CoA reductase activity into the organism, or
c) introducing at least one nucleic acid sequence coding for a dehydratase activity into the organism, and
d) cultivating the transgenic organism.

### Claim 28 (depends on 27)

The method according to claim 27, characterized in that the oil and/or lipid is isolated from the transgenic organism.

### Claim 29 (depends on 27)

The method according to claim 27, characterized in that the nucleic acid sequence coding for a polypeptide or a protein exhibiting phospholipase A2, ketoacyl-CoA reductase or dehydratase activity is selected from the group consisting of:
a) a nucleic acid sequence having the sequence depicted in SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5 or SEQ ID NO: 7,
b) a nucleic acid sequence which encodes one of the amino acid sequences depicted in SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6 or SEQ ID NO: 8, and
c) a derivative of the nucleic acid sequence depicted in SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5 or SEQ ID NO: 7 coding for a polypeptide or a protein having at least 40% identity at the amino acid level to SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6 or SEQ ID NO: 8 and exhibiting phospholipase A2, ketoacyl-CoA reductase or dehydratase activity.

### Claim 30 (depends on 27)

The method according to claim 27, characterized in that at least one nucleic acid sequence coding for a polypeptide or a protein exhibiting Δ-12 desaturase, Δ-9 elongase, Δ-8 desaturase, Δ-6 desaturase, Δ-6 elongase, Δ-5 desaturase, Δ-5 elongase, ω-3 desaturase, Δ-4 desaturase activity is additionally introduced into the organism.

### Claim 31 (depends on 27)

The method according to claim 27, characterized in that the oil and/or lipid is selected from the group consisting of linoleic acid, γ-linolenic acid, stearidonic acid, dihomo-γ-linolenic acid, ω-3-eicosatetraenoic acid, arachidonic acid, eicosapentaenoic acid, ω-6-docosapentaenoic acid, ω-6-docosatetraenoic acid, ω-3-docosapentaenoic acid and docosahexaenoic acid.

### Claim 32 (depends on 27)

The method according to claim 27, characterized in that the polyunsaturated fatty acids are isolated from the oil and/or lipid in the form of free fatty acids.

### Claim 33 (depends on 27)

The method according to claim 27, characterized in that the transgenic organism is a transgenic microorganism or a transgenic plant.

### Claim 34 (depends on 27)

The method according to claim 27, characterized in that the transgenic organism is an oil-producing plant, a vegetable plant, or an ornamental plant.

### Claim 35 (depends on 27)

The method according to claim 27, characterized in that the transgenic organism is a transgenic plant selected from the group consisting of plant classes or families: Adelotheciaceae, Anacardiaceae, Asteraceae, Apiaceae, Betulaceae, Boraginaceae, Brassicaceae, Bromeliaceae, Caricaceae, Cannabaceae, Convolvulaceae, Chenopodiaceae, Crypthecodiniaceae, Cucurbitaceae, Ditrichaceae, Elaeagnaceae, Ericaceae, Euphorbiaceae, Fabaceae, Geraniaceae, Gramineae, Juglandaceae, Lauraceae, Leguminosae, Linaceae and Prasinophyceae.

### Claim 36 (depends on 32)

The method according to claim 32, characterized in that the free fatty acids are isolated at a concentration of at least 5% by weight, based on the total lipid content of the transgenic organism.

### Claim 37 (depends on 27)

Oils, lipids or fatty acids or a fraction thereof, produced by the method according to claim 27.

### Claim 38 (depends on 27)

An oil, lipid or fatty acid composition comprising the polyunsaturated fatty acids produced by the method according to claim 27 and originated from a transgenic plant.

### Claim 39 (depends on 37)

A method for producing an oil, lipid or fatty acid composition by mixing oil, lipids or fatty acids according to claim 37 with animal oil, lipids or fatty acids.

### Claim 40 (depends on 37)

Feed, food, cosmetics or pharmaceuticals comprising oil, lipids or fatty acids according to claim 37.

### Claim 41

An isolated nucleic acid sequence coding for a polypeptide or a protein exhibiting phospholipase A2 activity, characterized in that the nucleic acid sequence is selected from the group consisting of:
a) a nucleic acid sequence having the sequence depicted in SEQ ID NO: 1,
b) a nucleic acid sequence which encodes the amino acid sequence depicted in SEQ ID NO: 2, and
c) a derivative of the nucleic acid sequence depicted in SEQ ID NO: 1, which codes for a polypeptide or a protein having at least 40% homology at the amino acid level to SEQ ID NO: 2 and exhibiting a phospholipase A2 activity.

### Claim 42

An isolated nucleic acid sequence coding for a polypeptide or a protein exhibiting ketoacyl-CoA reductase activity, selected from the group consisting of:
a) a nucleic acid sequence having the sequence depicted in SEQ ID NO: 3,
b) a nucleic acid sequence which encodes the amino acid sequence depicted in SEQ ID NO: 4, and
c) a derivative of the nucleic acid sequence depicted in SEQ ID NO: 3, which codes for a polypeptide or a protein having at least 40% homology at the amino acid level to SEQ ID NO: 4 and exhibiting a ketoacyl-CoA reductase activity.

### Claim 43

An isolated nucleic acid sequence coding for a polypeptide or a protein exhibiting dehydratase activity, selected from the group consisting of:
a) a nucleic acid sequence having the sequence depicted in SEQ ID NO: 5 or SEQ ID NO: 7,
b) a nucleic acid sequence which encodes one of the amino acid sequences depicted in SEQ ID NO: 6 or SEQ ID NO: 8, and
c) a derivative of the nucleic acid sequence depicted in SEQ ID NO: 5 or SEQ ID NO: 7, which codes for a polypeptide or a protein having at least 40% identity at the amino acid level to SEQ ID NO: 6 or SEQ ID NO: 8 and exhibiting a dehydratase activity.

### Claim 44 (depends on 41)

The isolated nucleic acid sequence according to claim 41, wherein the sequence is originated from an alga, a fungus, a microorganism, a plant, or a non-human animal.

### Claim 45 (depends on 41)

The isolated nucleic acid sequence according to claim 41, wherein the sequence is originated from the order Salmoniformes, the diatoms genera Thalassiosira or Crypthecodinium, the classes Prasinophyceae or Phycomycota, or the families Euglenaceae or Pythiaceae.

### Claim 46 (depends on 41)

An amino acid sequence encoded by the isolated nucleic acid sequence according to claim 41.

### Claim 47 (depends on 41)

A gene construct containing the isolated nucleic acid according to claim 41, wherein the nucleic acid is functionally linked to one or more regulatory signals.

### Claim 48 (depends on 47)

The Gene construct according to claim 47, characterized in that the nucleic acid construct contains at least one additional biosynthesis gene of the fatty acid or lipid metabolism selected from the group consisting of: acyl-CoA dehydrogenase(s), acyl-ACP [=acyl carrier protein] desaturase(s), acyl-ACP thioesterase(s), fatty acid acyltransferase(s), acyl-CoA:lysophospholipid acyltransferase(s), fatty acid synthase(s), fatty acid hydroxylase(s), acetyl-Coenzyme A carboxylase(s), acyl-Coenzyme A oxidase(s), fatty acid desaturase(s), fatty acid acetylenase(s), lipoxygenase(s), triacylglycerol lipase(s), allene oxide synthase(s), hydroperoxide lyases and fatty acid elongase(s).

### Claim 49 (depends on 47)

The gene construct according to claim 47, characterized in that the nucleic acid construct contains at least one additional biosynthesis gene of the fatty acid or lipid metabolism selected from the group consisting of Δ-4 desaturase, Δ-5 desaturase, Δ-6 desaturase, Δ-8 desaturase, Δ-9 desaturase, Δ-12 desaturase, Δ-6 elongase, Δ-5 elongase and Δ-9 elongase.

### Claim 50 (depends on 41)

A vector containing the nucleic acid according to claim 41.

### Claim 51 (depends on 41)

A transgenic non-human organism containing at least one nucleic acid according to claim 41.

### Claim 52 (depends on 51)

The transgenic non-human organism according to claim 51, wherein the organism is a plant.

### Claim 53 (depends on 42)

An amino acid sequence encoded by the isolated nucleic acid sequence according to claim 42.

### Claim 54 (depends on 42)

A gene construct containing the isolated nucleic acid according to claim 42, wherein the nucleic acid is functionally linked to one or more regulatory signals.

### Claim 55 (depends on 42)

A vector containing the nucleic acid according to claim 42.

### Claim 56 (depends on 42)

A transgenic non-human organism containing at least one nucleic acid according to claim 42.

### Claim 57 (depends on 43)

An amino acid sequence encoded by the isolated nucleic acid sequence according to claim 43.

### Claim 58 (depends on 43)

A gene construct containing the isolated nucleic acid according to claim 43, wherein the nucleic acid is functionally linked to one or more regulatory signals.

### Claim 59 (depends on 43)

A vector containing the nucleic acid according to claim 43.

### Claim 60 (depends on 43)

A transgenic non-human organism containing at least one nucleic acid according to claim 43.
